BeCareLink

BeCareLink is a private digital health company developing AI-enabled mobile applications and related digital biomarker tools for remote neurological assessment and monitoring. Its products are designed to quantify neurologic function outside the clinic, supporting earlier detection of decline, longitudinal tracking, and more standardized outcome measurement. The company appears to focus initially on multiple sclerosis and broader neurology use cases, while also expanding into applications for Alzheimer's disease, amyotrophic lateral sclerosis, and myasthenia gravis. BeCareLink positions its platform for both clinical care and pharmaceutical research, including decentralized and post-marketing studies. The business is best characterized as a healthcare technology and remote patient monitoring company rather than a therapeutic biotech or pharma developer.